Table 1 Baseline Characteristics of Single lung transplant subjects
From: Differences in airway microbiome and metabolome of single lung transplant recipients
S. No | Age | Gender | Side of Transplant | Duration of Transplant (months) | Pre-transplant diagnosis | IS | Prophylactic Antibiotic | BAL Culture | BAL cell count differential | CLAD at sample collection (Y/N) | CLAD at follow-up (2 years) (Y/N) |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 64 | M | Left | 20 | IPF | Tac, Pred, Aza | Val, Itra, Dapsone, | Negative | M-99%, N-1% | N | N |
2 | 57 | M | Right | 13 | CTD-ILD | Tac, Pred, MMF | TMP/SMX, Val, Vori | Negative | M-95%, L-3%, N- 2% | Y | Y |
3 | 64 | M | Left | 30 | IPF | Tac, Pred, MMF | Azithro, TMP/SMX, Val | Negative | M-10%, L-40%, N- 50% | N | Y |
4 | 69 | M | Left | 31 | IPF | Tac, Pred, Aza | Dapsone, Azithro, | Negative | M-93%, L-5%, N-2% | N | Y |
5 | 59 | F | Right | 18 | IPF | Tac, Aza Pred | TMP/SMX | Negative | M-38%, L- 54%, N 8% | N | Y |
6 | 62 | M | Left | 79 | IPF | Tac, Pred | Dapsone | 1000 CFU normal flora | M-58%, L-3%, N-39% | Y | Y |